Loss of Hippo signaling in Drosophila leads to tissue overgrowth as a result of increased cell proliferation and decreased cell death. YAP (a homolog of Drosophila Yorkie and target of the Hippo pathway) was recently implicated in control of organ size, epithelial tissue development, and tumorigenesis in mammals. However, the role of the mammalian Hippo pathway in such regulation has remained unclear. We now show that mice with liver-specific ablation of WW45 (a homolog of Drosophila Salvador and adaptor for the Hippo kinase) manifest increased liver size and expansion of hepatic progenitor cells (oval cells) and eventually develop hepatomas. Moreover, ablation of WW45 increased the abundance of YAP and induced its localization to the nucleus in oval cells, likely accounting for their increased proliferative capacity, but not in hepatocytes. Liver tumors that developed in mice heterozygous for WW45 deletion or with liver-specific WW45 ablation showed a mixed pathology combining characteristics of hepatocellular carcinoma and cholangiocarcinoma and seemed to originate from oval cells. Together, our results suggest that the mammalian Hippo-Salvador pathway restricts the proliferation of hepatic oval cells and thereby controls liver size and prevents the development of oval cellderived tumors.T he mammalian Hippo signaling pathway has been implicated in regulation of contact inhibition, organ size, and tumorigenesis (1-4). Such regulation is thought to be mediated by control of the expression level or localization of YAP, a major target of the Hippo pathway. YAP is overexpressed in certain mammalian cancers, and YAP transgenic mice show increased liver size and intestinal dysplasia and eventually develop liver tumors. The role of YAP in control of organ size and tumorigenesis prompted us to examine whether upstream components of the Hippo pathway indeed function to regulate YAP in this context. However, embryonic mortality (WW45 −/− , LATS2 −/− , MST1 −/− MST2 −/− , or YAP −/− ) or the absence of any overt enlargement of specific organs (LATS1 −/− ) in mice lacking such components has hampered this investigation (5-9). The generation of conditional knockout mice would thus seem to be warranted for investigation of the role of the mammalian Hippo pathway in the control of liver size and tumorigenesis.Primary liver tumors have been categorized into two major types: hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC), which originate from hepatocytes and cholangiocytes, respectively. However, some primary hepatomas exhibit an intermediate or combined (HCC/CC) phenotype and are thought to be derived from transformed progenitor (oval) cells or by dedifferentiation of mature cells (10-16). Oval cells are thought to be bipotential progenitor cells that can differentiate into either hepatocytes or ductal cholangiocytes but do so only if proliferation of hepatocytes is inhibited (17-19). However, the precise mechanism responsible for regulation of oval cell proliferation and how its deregulation contributes to tumor ...
ATAD5, the human ortholog of yeast Elg1, plays a role in PCNA deubiquitination. Since PCNA modification is important to regulate DNA damage bypass, ATAD5 may be important for suppression of genomic instability in mammals in vivo. To test this hypothesis, we generated heterozygous (Atad5+/m) mice that were haploinsuffficient for Atad5. Atad5+/m mice displayed high levels of genomic instability in vivo, and Atad5+/m mouse embryonic fibroblasts (MEFs) exhibited molecular defects in PCNA deubiquitination in response to DNA damage, as well as DNA damage hypersensitivity and high levels of genomic instability, apoptosis, and aneuploidy. Importantly, 90% of haploinsufficient Atad5+/m mice developed tumors, including sarcomas, carcinomas, and adenocarcinomas, between 11 and 20 months of age. High levels of genomic alterations were evident in tumors that arose in the Atad5+/m mice. Consistent with a role for Atad5 in suppressing tumorigenesis, we also identified somatic mutations of ATAD5 in 4.6% of sporadic human endometrial tumors, including two nonsense mutations that resulted in loss of proper ATAD5 function. Taken together, our findings indicate that loss-of-function mutations in mammalian Atad5 are sufficient to cause genomic instability and tumorigenesis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.